Syed Hasan to Adverse Drug Reaction Reporting Systems
This is a "connection" page, showing publications Syed Hasan has written about Adverse Drug Reaction Reporting Systems.
Connection Strength
0.589
-
Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19. Eur J Clin Pharmacol. 2021 Mar; 77(3):435-437.
Score: 0.589
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.